| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |